• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Birth and Maturation of Cardio-Oncology.

作者信息

Bhatt Deepak L

机构信息

Brigham and Women's Hospital Heart & Vascular Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

JACC CardioOncol. 2019 Sep 24;1(1):114-116. doi: 10.1016/j.jaccao.2019.08.004. eCollection 2019 Sep.

DOI:10.1016/j.jaccao.2019.08.004
PMID:34396168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352290/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f90/8352290/544defd40f7a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f90/8352290/5a78cc8ea96c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f90/8352290/544defd40f7a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f90/8352290/5a78cc8ea96c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f90/8352290/544defd40f7a/gr1.jpg

相似文献

1
Birth and Maturation of Cardio-Oncology.心脏肿瘤学的诞生与成熟
JACC CardioOncol. 2019 Sep 24;1(1):114-116. doi: 10.1016/j.jaccao.2019.08.004. eCollection 2019 Sep.
2
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.设立心脏肿瘤学科室的基本原理：我们在梅奥诊所的经验。
Cardiooncology. 2016 Apr 19;2(1):5. doi: 10.1186/s40959-016-0014-2.
3
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.肿瘤心脏病学计划：心血管疾病癌症患者护理的多学科方法。
Can J Cardiol. 2016 Jul;32(7):847-51. doi: 10.1016/j.cjca.2016.04.014. Epub 2016 May 6.
4
Modern concepts in cardio-oncology.心脏肿瘤学的现代概念。
J Thorac Dis. 2018 Dec;10(Suppl 35):S4386-S4390. doi: 10.21037/jtd.2018.11.110.
5
[Cardio-oncology, why is it a new specialty ?].[心脏肿瘤学，为何它是一门新兴专科？]
Rev Med Liege. 2021 May;76(5-6):408-412.
6
How to Develop a Cardio-Oncology Clinic.如何建立一个心脏肿瘤诊所。
Heart Fail Clin. 2017 Apr;13(2):347-359. doi: 10.1016/j.hfc.2016.12.011.
7
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用：心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
8
Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.巴西心血管肿瘤学：圣保罗州立癌症研究所的 10 年经验。
BMC Cardiovasc Disord. 2020 Apr 28;20(1):206. doi: 10.1186/s12872-020-01471-8.
9
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).心血管影像学在接受心脏毒性治疗的癌症患者中的作用：代表心力衰竭协会（HFA）、欧洲心血管影像协会（EACVI）和欧洲心脏病学会心脏肿瘤学委员会（ESC）的立场声明。
Eur J Heart Fail. 2020 Sep;22(9):1504-1524. doi: 10.1002/ejhf.1957. Epub 2020 Aug 21.
10
Cardio-Oncology Fellowship Training and Education.心血管肿瘤学 fellowship 培训与教育
Curr Treat Options Cardiovasc Med. 2019 May 18;21(6):27. doi: 10.1007/s11936-019-0733-4.

引用本文的文献

1
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review.GnRH拮抗剂与激动剂对前列腺癌心血管影响的比较：一项系统评价
JACC CardioOncol. 2023 Aug 1;5(5):613-624. doi: 10.1016/j.jaccao.2023.05.011. eCollection 2023 Oct.
2
Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions.循环心血管生物标志物与癌症治疗相关的心脏毒性：关键挑战、解决方案和未来方向的综述。
J Am Heart Assoc. 2023 Nov 7;12(21):e029574. doi: 10.1161/JAHA.123.029574. Epub 2023 Oct 27.
3
Tailored to a Woman's Heart: Gender Cardio-Oncology Across the Lifespan.

本文引用的文献

1
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.美国国立卫生研究院资助的心脏肿瘤学研究的不断发展的设计，以解决癌症治疗相关的心血管毒性。
JACC CardioOncol. 2019 Sep;1(1):105-113. doi: 10.1016/j.jaccao.2019.08.007. Epub 2019 Sep 24.
2
Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.免疫检查点抑制剂的心血管毒性：JACC 每周综述专题。
J Am Coll Cardiol. 2019 Oct 1;74(13):1714-1727. doi: 10.1016/j.jacc.2019.07.079.
3
Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
为女性心脏定制：全生命周期女性心血管肿瘤学。
Curr Cardiol Rep. 2023 Nov;25(11):1461-1474. doi: 10.1007/s11886-023-01967-7. Epub 2023 Oct 11.
4
Advancing Cardio-Oncology in Asia.推动亚洲心血管肿瘤学发展。
Korean Circ J. 2023 Feb;53(2):69-91. doi: 10.4070/kcj.2022.0255.
5
Survival of cancer patients with pre-existing heart disease.患有基础心脏病癌症患者的生存率。
BMC Cancer. 2022 Aug 3;22(1):847. doi: 10.1186/s12885-022-09944-z.
6
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: State-of-the-Art Review.癌症、心房颤动、动脉粥样硬化和血栓形成的共同病理生理学：最新综述
JACC CardioOncol. 2021 Nov 16;3(5):619-634. doi: 10.1016/j.jaccao.2021.08.011. eCollection 2021 Dec.
7
Cardiovascular Safety Assessment in Cancer Drug Development.肿瘤药物研发中心血管安全性评估
J Am Heart Assoc. 2021 Dec 21;10(24):e024033. doi: 10.1161/JAHA.121.024033. Epub 2021 Dec 16.
8
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.前列腺癌患者中地加瑞克与亮丙瑞林的心血管安全性：PRONOUNCE 随机试验的主要结果。
Circulation. 2021 Oct 19;144(16):1295-1307. doi: 10.1161/CIRCULATIONAHA.121.056810. Epub 2021 Aug 30.
9
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design.地加瑞克与亮丙瑞林治疗晚期前列腺癌的心血管安全性：PRONOUNCE试验研究设计
JACC CardioOncol. 2020 Mar 17;2(1):70-81. doi: 10.1016/j.jaccao.2020.01.004. eCollection 2020 Mar.
10
Cardiology Involvement in Patients with Breast Cancer Treated with Trastuzumab.曲妥珠单抗治疗的乳腺癌患者的心脏受累情况
JACC CardioOncol. 2020 Jun;2(2):179-189. doi: 10.1016/j.jaccao.2020.04.010. Epub 2020 Jun 16.
克隆性造血的不确定潜能重塑与年龄相关的心血管疾病：JACC 本周综述专题。
J Am Coll Cardiol. 2019 Jul 30;74(4):578-586. doi: 10.1016/j.jacc.2019.05.045.
4
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.克隆性造血：衰老、心血管疾病和癌症的交汇点：JACC 本周综述专题。
J Am Coll Cardiol. 2019 Jul 30;74(4):567-577. doi: 10.1016/j.jacc.2019.06.007.
5
Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week.为肿瘤患者提供心血管保健服务：JACC 本周综述主题。
J Am Coll Cardiol. 2019 May 7;73(17):2226-2235. doi: 10.1016/j.jacc.2019.02.041.
6
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.心血管肿瘤学：血管和代谢视角：美国心脏协会的科学声明。
Circulation. 2019 Mar 26;139(13):e579-e602. doi: 10.1161/CIR.0000000000000641.
7
Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity.卡维地洛预防蒽环类药物所致心脏毒性的荟萃分析。
Am J Cardiol. 2018 Dec 1;122(11):1959-1964. doi: 10.1016/j.amjcard.2018.08.039. Epub 2018 Sep 8.
8
Adaptive Designs for Clinical Trials.临床试验的适应性设计
N Engl J Med. 2016 Jul 7;375(1):65-74. doi: 10.1056/NEJMra1510061.
9
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons.美国心脏病学会/美国心脏协会/胸外科医师协会关于注册登记与绩效评估事业未来的声明：美国心脏病学会/美国心脏协会绩效评估特别工作组及胸外科医师协会报告
J Am Coll Cardiol. 2015 Nov 17;66(20):2230-2245. doi: 10.1016/j.jacc.2015.07.010. Epub 2015 Oct 2.
10
Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not.
JAMA. 2010 Jun 2;303(21):2188-9. doi: 10.1001/jama.2010.743.